Evidence map›Paper›PMID 40493559›Full record

ArticlePloS one2025

Protocol for evaluating the cost-effectiveness of Mongolia's sugar-sweetened beverages tax using double machine learning.

Nyamdavaa Byambadorj, Rohan Best, Undram Mandakh, Kompal Sinha

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nyamdavaa ByambadorjDepartment of Economics, Macquarie Business School, Macquarie University, Sydney, New South Wales, Australia.ORCID https://orcid.org/0000-0002-1899-3974
Rohan BestDepartment of Economics, Macquarie Business School, Macquarie University, Sydney, New South Wales, Australia.ORCID https://orcid.org/0000-0002-9333-6149
Undram MandakhDepartment of Family Medicine, School of Medicine, Mongolian National University of Medical Science, Ulaanbaatar, Mongolia.
Kompal SinhaDepartment of Economics, Macquarie Business School, Macquarie University, Sydney, New South Wales, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Elevated consumption of sugar-sweetened beverages (SSBs) has been associated with an increase in obesity, type 2 diabetes, and other non-communicable diseases (NCDs), a significant health and economic burden on Mongolia. To address this, the government has introduced a 20% SSB tax set to take effect in 2027. This study conducts a Cost-Effectiveness Analysis (CEA) using a Markov cohort model, incorporating Double Machine Learning (DML) to estimate price elasticity and assess policy-driven consumption changes while addressing potential confounding. The analysis integrates DML-estimated price elasticity and consumption shifts with disease transition probabilities, simulating outcomes for the 2023 Mongolian population, aged over 15 years old, over two time horizons of 20 years and a lifetime. The model estimates changes in obesity prevalence, healthcare costs, and disease burden, translating them into Disability-Adjusted Life Years (DALYs) averted, and Quality-Adjusted Life Years (QALYs) gained. Tax revenue projections and sensitivity analyses further assess the robustness of assumptions. By combining machine learning-based causal inference with economic modelling, this study provides policy-relevant evidence on the cost-effectiveness of SSB taxation, supporting data-driven decision-making for public health strategies in Mongolia, highlighting the tax's potential to reduce the burden of NCDs and promote healthier behaviours.

Indexed as

Cost-Benefit AnalysisMachine LearningSugar-Sweetened BeveragesTaxesAdolescentAdultDisability-Adjusted Life YearsFemaleHumansMaleMarkov ChainsMiddle AgedModels, EconomicMongoliaObesityQuality-Adjusted Life Years

Identifiers

PMID40493559
PMCPMC12151437

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.